Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
59.60K | 1.71K | 66.57K | 3.56K | 0.00 | 358.14K | Gross Profit |
59.60K | 1.71K | 66.57K | 3.56K | 0.00 | 358.14K | EBIT |
-5.63M | -4.84M | -38.95M | -3.83M | -3.67M | ― | EBITDA |
11.28M | 11.98M | -40.78M | -5.11M | -4.57M | -20.86M | Net Income Common Stockholders |
-22.14M | -21.25M | -36.55M | -7.99M | -3.63M | ― |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.10M | 2.98M | 4.12M | 3.49M | 13.36M | 18.73M | Total Assets |
27.18M | 31.26M | 55.62M | 45.87M | 16.93M | 19.89M | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 348.90K | 0.00 | Net Debt |
-6.03M | -2.97M | -4.11M | -3.44M | -11.46M | -18.67M | Total Liabilities |
829.31K | 1.25M | 4.97M | 5.65M | 947.08K | 350.37K | Stockholders Equity |
26.35M | 30.02M | 50.65M | 40.22M | 16.03M | 19.54M |
Cash Flow | Free Cash Flow | ||||
-6.37M | -5.33M | -37.39M | -4.63M | -5.25M | ― | Operating Cash Flow |
-6.37M | -5.33M | -35.79M | -4.63M | -3.50M | ― | Investing Cash Flow |
10.12M | 4.30M | 948.24K | -8.50M | -3.31M | 0.00 | Financing Cash Flow |
0.00 | 0.00 | 35.67M | 4.87M | 0.00 | 15.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $2.10B | 13.55 | 7.57% | 3.95% | -0.17% | 76.67% | |
73 Outperform | $2.37B | 6.95 | 9.38% | 11.18% | 3.08% | -30.22% | |
62 Neutral | C$3.62B | 74.38 | 3.62% | 5.52% | -2.25% | -3.28% | |
57 Neutral | $8.36B | 5.47 | -5.51% | 7.41% | 0.15% | -68.69% | |
44 Neutral | C$16.09M | ― | -119.19% | ― | -27.09% | -681.10% | |
42 Neutral | $792.93M | ― | -38.67% | 3.90% | ― | -438.52% | |
34 Underperform | £52.01M | ― | -58.84% | ― | ― | -549.19% |